主要文件

查看所有文档

SML4253

PRGL493

Name: PRGL493
Brand: SIGMA

≥98% (HPLC), powder, ACSL4 inhibitor

别名:

N-(4-(3-(5-methylfuran-2-yl)-1-phenyl-1H-pyrazol-4-yl)-3,4-dihydrobenzo[4,5]imidazo[1,2-a][1,3,5]triazin-2-yl)acetamide, N-[1,4-Dihydro-4-[3-(5-methyl-2-furanyl)-1-phenyl-1H-pyrazol-4-yl]-1,3,5-triazino[1,2-a]benzimidazol-2-yl]acetamide

登录并加购，请在购物车里查看协议价、货期和发货地。

选择规格

变更视图

关于此项目

经验公式（希尔记法）:

C₂₅H₂₁N₇O₂

化学文摘社编号:

2479378-45-3

分子量:

451.48

NACRES:

NA.21

Assay:

≥98% (HPLC)

Form:

powder

技术服务

需要帮助？我们经验丰富的科学家团队随时乐意为您服务。

让我们为您提供帮助

属性

Quality Segment

100

assay

≥98% (HPLC)

form

powder

color

white to beige

solubility

DMSO: 2 mg/mL, clear (warmed)

storage temp.

-10 to -25°C

SMILES string

CC(NC1=NC(N2C(C3=CN(C4=CC=CC=C4)N=C3C5=CC=C(C)O5)N1)=NC6=C2C=CC=C6)=O

说明

Application

PRGL493 may be used to study:

the role of ACSL4 in endometrial receptivity disorders, using mouse endometriosis model
its therapeutic effects in severe acute pancreatitis model in mice

Biochem/physiol Actions

PRGL493, a highly effective and selective Acyl-CoA synthetase 4 (ACSL4) inhibitor, exhibits potent anti-tumor activities by inhibiting cell proliferation and tumor growth in breast and prostate cancer models, both in vitro (IC50 ~ 25 µM) and in vivo (250 μg/kg, i.p., in mice). PRGL493 functions mainly by reducing ABCG2 (ATP-binding cassette subfamily G member 2) in TNBC and promoting ER expression. PRGL-493 effectively disrupts steroidogenesis, demonstrated by the significant reduction of steroid levels in cell lines and mouse models. Additionally, PRGL493 enhances the sensitivity of cancer cells to conventional chemotherapeutic and hormonal treatments.

pictograms

GHS07

signalword

Warning

hcodes

H302

pcodes

P264 - P270 - P301 + P312 - P501

Hazard Classifications

Acute Tox. 4 Oral

存储类别

10 - Combustible liquids

flash_point_f

Not applicable

flash_point_c